Chemical Compound Review:
AG-K-56770 (3R,6S,11S,14S,20S,23S)-6- acetamido-3...
Synonyms:
MK-0852, KST-1A1805, CTK0H9338, AR-1A6968, MK 852, ...
- Platelet GPIIb/IIIa receptor blockade reduces infarct size in a canine model of ischemia-reperfusion. Kingma, J.G., Plante, S., Bogaty, P. J. Am. Coll. Cardiol. (2000)
- Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis. Ramjit, D.R., Lynch, J.J., Sitko, G.R., Mellott, M.J., Holahan, M.A., Stabilito, I.I., Stranieri, M.T., Zhang, G., Lynch, R.J., Manno, P.D. J. Pharmacol. Exp. Ther. (1993)
- Inhibition of fibrinogen binding and surface recruitment of GpIIb/IIIa as dose-dependent effects of the RGD-mimetic MK-852. Wittig, K., Rothe, G., Schmitz, G. Thromb. Haemost. (1998)
- Antiplatelet effects of MK-852, a platelet fibrinogen receptor antagonist, in healthy volunteers. Greenberg, H.E., Wissel, P., Barrett, J., Barchowsky, A., Gould, R., Farrell, D., Panebianco, D., Hand, E., Gillen, L., Goldberg, M.R., Bjornsson, T.D. Journal of clinical pharmacology. (2000)
- Changes in the composition of the platelet cytoskeleton in response to ADP: effects of MK-852 and ARL 66096. May, J.A., Heptinstall, S., Spangenberg, P. Blood Coagul. Fibrinolysis (1996)
- The effects of GPIIb-IIIa antagonists and a combination of three other antiplatelet agents on platelet-leukocyte interactions. Zhao, L., Bath, P.M., Fox, S., May, J., Judge, H., Lösche, W., Heptinstall, S. Current medical research and opinion. (2003)
- Dose-responses to inducers and inhibitors of platelet aggregation analysed via a micro-method. Hoylaerts, M.F., Thys, C., Stassen, J.M., Vermylen, J. Blood Coagul. Fibrinolysis (1996)
- Determination of MK-852, a new fibrinogen receptor antagonist, in plasma and urine by radioimmunoassay. Yuan, A.S., Hand, E.L., Hichens, M., Olah, T.V., Barrish, A., Fernandez-Metzler, C., Gilbert, J.D. Journal of pharmaceutical and biomedical analysis. (1993)